3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Vitamin’s effect on cancer varies by smoker status

CancerSep 21, 05

High intake of beta-carotene seems to decrease the risk of tobacco-related cancers among people who’ve never smoked, but to increase the risk among current or past smokers, new research suggests. Although the findings are based on a study of women, the researchers believe that similar results would be obtained in men.

“Based on the findings from our study and others, I would advise against beta-carotene supplements for current or past smokers,” senior author Dr. Marie-Christine Boutron-Ruault, from INSERM in Villejuif, France, told Reuters Health. “For beta-carotene-rich foods, the message is less clear, since they often contain other vitamins that may counteract the interaction of beta-carotene with smoking.”

The new study, which is reported in the Journal of the National Cancer Institute, involved an evaluation of beta-carotene intake for 59,910 women who were followed for about 7 years to assess cancer occurrence. During follow-up, 700 women developed tobacco-related cancers, such as lung cancer or head and neck cancer.

Among never smokers, consuming a diet containing moderate amounts of beta-carotene cut the risk of cancer by up to 28 percent. Taking beta-carotene supplements reduced the risk by 56 percent.

Just the opposite effect was seen in current or past smokers. In this group, consuming a diet containing moderate amounts of beta-carotene increased the risk of cancer by up to 43 percent. Taking beta-carotene supplements more than doubled the risk of cancer.

“We were surprised at the completely opposite effect high beta-carotene intake had on cancer risk depending on whether you had never smoked or ever smoked,” Boutron-Ruault noted.

“We plan on doing a larger study with more cancer cases, a larger variety of doses of beta-carotene and tobacco, and both men and women” to verify and expand on the current findings, she added.

SOURCE: Journal of the National Cancer Institute, September 21, 2005.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site